Related Experiment Video
Updated: Jan 10, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
'The monthly curse': menstrual-associated coronary artery vasospasm in a premenopausal woman-a case report
Akari Odagi1, Kensuke Matsumoto1, Tetsu Yamazaki1
1Division of Cardiovascular Medicine, Department of Internal Medicine, Hyogo Prefectural Tamba Medical Centre, 2002-7, Isou, Hikami-cho, Tamba-shi, Hyogo, Tamba 669-3495, Japan.
Background:
Catamenial coronary vasospasm has recently been recognized as a refractory form of vasospastic angina, characterized by recurrent episodes of chest pain that are temporally associated with the menstrual cycle.
Case Summary:
A 38-year-old premenopausal woman presented to our hospital with chest pain. Upon entering the cold examination room, she experienced chest pain identical in character to her previous episodes. Electrocardiography revealed ST-segment elevation in the inferior leads. Sublingual administration of nitroglycerin resulted in the prompt relief of symptoms and resolution of ST-segment changes. Subsequent coronary angiography revealed no obstructive coronary lesions, leading to the diagnosis of coronary vasospasm. A comprehensive clinical history revealed that all episodes of chest pain occurred consistently in the days preceding the onset of menstruation. She was closely monitored in an outpatient setting and was prescribed a combination of benidipine and nicorandil. Unfortunately, the patient was transferred to our hospital following an episode of cardiopulmonary arrest. Emergency coronary angiography revealed critical stenosis due to vasospasm in the ostium of the right coronary artery. The patient died despite receiving intensive care.
Discussion:
During the late luteal and menstrual phases, circulating oestrogen levels decline to their lowest point, potentially increasing susceptibility to coronary vasospasms. In recent years, oestrogen replacement therapy has been reported to confer therapeutic benefits in this patient population. Early multidisciplinary collaboration involving gynaecologists and timely initiation of hormonal therapy may alter the clinical course and prevent fatal outcomes in such patients.
Related Concept Videos
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome V: Nursing Management
Angina I: Introduction
Acute Coronary Syndrome I: Introduction

